Noncoding RNA: Aging well with Norad
Aging is a complex process that affects most living organisms. Over a century of research has revealed that many different intrinsic and extrinsic factors contribute to our bodies growing old, but we are still a long way from a full understanding of all the mechanisms at play. Recent research has implicated molecules that do not code for proteins in this process, such as long noncoding RNAs. For instance, many of these so-called 'lncRNAs' are expressed differently in patients with age-related disorders, such as various forms of neurodegenerative disease and cancer (Rinn and Chang, 2012).
Now, in eLife, Joshua Mendell of the University of Texas Southwestern Medical Center (UTSW) and colleagues – including Florian Kopp as first author – report that losing the long noncoding RNA Norad accelerates aging in mice (Kopp et al., 2019). Previous studies have shown that Norad is highly conserved in mammals, and that it is abundant in most human cells (Lee et al., 2016; Tichon et al., 2016). The production of Norad increases in response to DNA damage and it helps preserve the genetic information as cells divide. Norad is mainly found in the cytoplasm, where it can bind two PUMILIO proteins (PUM1 and PUM2) that regulate a variety of targets in the cell, including some involved in cell growth and division (Figure 1). Yet, it was unknown what deleting Norad would entail at the level of an organism.
To investigate this question, Kopp et al. – who are based at UTSW, the Nationwide Children's Hospital and Ohio State University – engineered mice that lacked Norad. As the mutant animals grew, they displayed signs of premature aging: their fur thinned down and grayed faster; their spine showed the abnormal curvature associated with old age; their fat reserves dwindled more quickly; and they died earlier. Mice lacking Norad also exhibited several cellular hallmarks of aging (López-Otín et al., 2013). Many of their cells had the wrong number of chromosomes (as previously seen in Norad-deficient human cells), as well as mitochondria that were showing defects. This was associated with the repression of PUMILIO targets that keep mitochondria working properly. Strikingly, mice engineered to over-produce PUM2 had similar characteristics, clearly indicating that the hyperactivity of PUMILIO drives the symptoms associated with a lack of Norad (Figure 1).
On the flipside, a recent study in humans showed that halving the dose of PUM1 leads to developmental delay and seizures (Gennarino et al., 2018), and reducing the amount of PUM1, PUM2, or both results in smaller body size (Lin et al., 2019). These results suggest that mammals must maintain the activity of PUMILIO proteins within a narrow range in order to remain healthy. In fact, the levels of PUM2 proteins in bulk tissues are indistinguishable between control mice and animals that overexpress Pum2. Furthermore, in both Norad-deficient and Pum2-overexpressing mice, most PUMILIO targets are only affected very mildly, yet the animals exhibit striking phenotypes. Kopp et al. argue that repressing many PUMILIO targets at the same time, even weakly, may trigger the physiological damages observed in these rodents.
Still, it may also be possible that when the Norad-PUMILIO axis is disrupted, certain cells or tissues are more likely to stop working properly, which in turn creates a snowball effect for the whole organism. For instance, the expression of Norad is highest in the human brain, but it decreases with age in a region that acts as a reservoir to regenerate brain cells (Barry et al., 2015). In simpler organisms, such as the worm C. elegans, the nervous system acts on other tissues to coordinate pathways that keep proteins in their normal conformation, but these mechanisms become defective with age (van Oosten-Hawle and Morimoto, 2014). It remains unclear whether the nervous system performs such roles in mammals; yet, these results raise the possibility that interactions between Norad and PUMILIO are needed in specific tissues to ward off the effects of age.
Norad is PUMILIO’s preferred target, and has several binding sites that are recognized by these proteins. This suggests that this lncRNA can bind a large number of PUMILIO proteins at any given moment, but it is still unclear whether Norad tempers the activity of PUM1 and PUM2 simply by competing with other targets of PUMILIO, or if another mechanism is at play (Goldstrohm et al., 2018; Tichon et al., 2018).
Curiously, Norad is only found in mammals, whereas the PUMILIO proteins are found in all eukaryotes; it is therefore possible that RNAs with different sequences also buffer the activity of PUMILIO in other species. It remains to be seen how and why mammalian cells rely on Norad to tame the activity of these proteins, as opposed to other types of regulatory mechanisms. Ultimately, the work by Kopp et al. sets the ground for further enquiries into the role of noncoding RNAs and RNA-binding proteins in aging, which could potentially yield new therapeutic approaches for diseases brought by old age.
References
-
Post-transcriptional regulatory functions of mammalian Pumilio proteinsTrends in Genetics 34:972–990.https://doi.org/10.1016/j.tig.2018.09.006
-
Genome regulation by long noncoding RNAsAnnual Review of Biochemistry 81:145–166.https://doi.org/10.1146/annurev-biochem-051410-092902
Article and author information
Author details
Publication history
Copyright
© 2019, Marques and Ulitsky
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,518
- views
-
- 209
- downloads
-
- 7
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Chromosomes and Gene Expression
Cells evoke the DNA damage checkpoint (DDC) to inhibit mitosis in the presence of DNA double-strand breaks (DSBs) to allow more time for DNA repair. In budding yeast, a single irreparable DSB is sufficient to activate the DDC and induce cell cycle arrest prior to anaphase for about 12–15 hr, after which cells ‘adapt’ to the damage by extinguishing the DDC and resuming the cell cycle. While activation of the DNA damage-dependent cell cycle arrest is well understood, how it is maintained remains unclear. To address this, we conditionally depleted key DDC proteins after the DDC was fully activated and monitored changes in the maintenance of cell cycle arrest. Degradation of Ddc2ATRIP, Rad9, Rad24, or Rad53CHK2 results in premature resumption of the cell cycle, indicating that these DDC factors are required both to establish and maintain the arrest. Dun1 is required for the establishment, but not the maintenance, of arrest, whereas Chk1 is required for prolonged maintenance but not for initial establishment of the mitotic arrest. When the cells are challenged with two persistent DSBs, they remain permanently arrested. This permanent arrest is initially dependent on the continuous presence of Ddc2, Rad9, and Rad53; however, after 15 hr these proteins become dispensable. Instead, the continued mitotic arrest is sustained by spindle assembly checkpoint (SAC) proteins Mad1, Mad2, and Bub2 but not by Bub2’s binding partner Bfa1. These data suggest that prolonged cell cycle arrest in response to 2 DSBs is achieved by a handoff from the DDC to specific components of the SAC. Furthermore, the establishment and maintenance of DNA damage-induced cell cycle arrest require overlapping but different sets of factors.
-
- Chromosomes and Gene Expression
- Developmental Biology
Transcription often occurs in bursts as gene promoters switch stochastically between active and inactive states. Enhancers can dictate transcriptional activity in animal development through the modulation of burst frequency, duration, or amplitude. Previous studies observed that different enhancers can achieve a wide range of transcriptional outputs through the same strategies of bursting control. For example, in Berrocal et al., 2020, we showed that despite responding to different transcription factors, all even-skipped enhancers increase transcription by upregulating burst frequency and amplitude while burst duration remains largely constant. These shared bursting strategies suggest that a unified molecular mechanism constraints how enhancers modulate transcriptional output. Alternatively, different enhancers could have converged on the same bursting control strategy because of natural selection favoring one of these particular strategies. To distinguish between these two scenarios, we compared transcriptional bursting between endogenous and ectopic gene expression patterns. Because enhancers act under different regulatory inputs in ectopic patterns, dissimilar bursting control strategies between endogenous and ectopic patterns would suggest that enhancers adapted their bursting strategies to their trans-regulatory environment. Here, we generated ectopic even-skipped transcription patterns in fruit fly embryos and discovered that bursting strategies remain consistent in endogenous and ectopic even-skipped expression. These results provide evidence for a unified molecular mechanism shaping even-skipped bursting strategies and serve as a starting point to uncover the realm of strategies employed by other enhancers.